Microsoft Word - Lecture 6 Cont 09-10
Microsoft Word - Lecture 6 Cont 09-10
Lecture 6 (Continued)
1
A part of Good Manufacturing Practice (GMP), the production run is
monitored under control chart. At regular intervals (10-15 min.)
during the course of manufacturing, the operator must sample
specified number of tablets for testing (in-process control) e.g.
weight of tablet, tablet thickness, friability, disintegration time, …
Non-Compandial tests
There are many tests are frequently applied to tablets for which
there are non-pharmacopoeial requirements but will form a part
of manufacture's owner product specifications.
1- Tablet thickness.
2- Tablet hardness.
I- Non-Compandial tests:
1. Tablet thickness
Tablet thickness is important for tablet packaging; very thick
tablets affect packaging either in blisters or plastic containers.
2
Micrometer (tablet thickness) (Tablet thickness & diameter)
2. Hardness test
If the drug forms greater part of the tablet, any variation in the
tablet weight obviously indicates a variation in the active
ingredient. (Weight uniformity test)
5
If the drug is potent (USP specifies 50 mg of the active ingredient
or less), the excipients form the greater part of the tablet weight
and the correlation between the tablet weight and amount of the
active ingredient can be poor, in this case another test (Content
uniformity) must be performed.
A. Weight uniformity
B.P. design:
Not more than two of the individual weights (for example, X1 and
X7) deviate from the average weight (X) by more than the %
deviation shown in the table below and none deviates by more
than twice that %:
6
% Error for a tablet=
Difference between Actual tablet weight & Average tablet weight x 100
Average tablet weight
Tablet
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
no
%
0.86 0.12 5.82 1.61 0.37 0.86 1.85 5.82 1.36 0.6 4.08 9.04 4.08 0.37 0.12 1.36 5.82 3.34 0.86 0.86
error
Pharmacopoeial requirement:
Not more than two of the individual tablet weights deviate from
the average weight (X) by more than 7.5% according to the
following table and none deviate by double this %:
Test result: Only one tablet (tablet number 12) deviated >7.5%,
and this deviation (%error 9.04 %) is less than 15 %, i.e. tablets
passed this test successfully
B. Content uniformity
USP defines content uniformity test for tablets containing 50 mg
or less of drug substance in case of uncoated tablets and for
all sugar coated tablets regardless to the drug content.
USP design:
Ten tablets are individually assayed for their content (according
to the method described in the individual monograph)
The requirements for content uniformity are met if the amount of
the active ingredient in each tablet lies within the range of 85-
115 % of the label claim.
(If one or more tablet does not meet these criteria, additional tests as
prescribed in the USP are required)
7
If content uniformity test is required, the weight uniformity test is not
required
I- Match:
- Friability test
1- USP quality control test performed for tablets containing - Dissolution test
20mg drug to ensure that each include the correct dose
2- Quality control test performed for tablets to ensure that - Hardness test
each shows sufficient mechanical strength
3- Quality control test performed for tablets to ensure that - Weight uniformity
the drug is released in a controlled and reproducible way
- Content uniformity
4- If content uniformity test is required, the weight uniformity test is not required
7- Content uniformity test is essential for all sugar coated tablets regardless to
their drug content
8- In weight uniformity test, tablets are individually assayed for their content
Remember
No Quizzes will be held next week during lab sessions (16, 18/11/2009)
Uxáà j|á{xá